Anxiety Disorders Clinical Trials

Birmingham : Forest Investigative Site 001

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Arcadia : Forest Investigative Site 022

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Beverly Hills : Forest Investigative Site 023

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Encino : Forest Investigative Site 010

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Glendale : Forest Investigative Site 023

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Newport Beach : Forest Investigative Site 025

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

View More »

Redlands : Forest Investigative Site 004

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

San Diego : University of California, San Diego

Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder

Sherman Oaks : Forest Investigative Site 007

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Temecula : Forest Investigative Site 016

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Upland : Forest Investigative Site 012

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Norwich : Forest Investigative Site 026

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Waterbury : Forest Investigative Site 027

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Washington : US003

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Coral Springs : Forest Investigative Site 017

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Delray Beach : Forest Investigative Site 005

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Fort Myers : Forest Investigative Site 028

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Jacksonville : Forest Investigative Site 002

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Leesburg : Forest Investigative Site 020

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

View More »

Miami : Forest Investigative Site 024

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Oakland Park : Forest Investigative Site 014

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Orlando : Forest Investigative Site 001

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

South Miami : Forest Investigative Site 019

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Decatur : Forest Investigative Site 035

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Chicago : Forest Investigative Site 028

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Schaumburg : Forest Investigative Site 030

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Indianapolis : Forest Investigative Site 026

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Topeka : Forest Investigative Site 029

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Wichita : US004

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Wichita : Forest Investigative Site 033

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Lake Charles : Forest Investigative Site 010

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Shreveport : Forest Investigative Site 029

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Boston : Forest Investigative Site 025

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Birmingham : Vision Specialists of Birmingham

Effects of Prismatic Spectacle Lenses on Symptoms of Dizziness, Headache and Anxiety as Caused by Vertical Heterophoria

St. Louis : Forest Investigative Site 037

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Las Vegas : Forest Investigative Site 019

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Berlin : Forest Investigative Site 016

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

New York : Forest Investigative Site 024

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

New York : Forest Investigative Site 012

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

New York : Forest Investigative Site 032

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

New York : The Medical Research Network, LLC

Study of Vilazodone to Treat Social Anxiety Disorder

Bismarck : Forest Investigative Site 020

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Canton : Forest Investigative Site 003

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Cincinnati : US002

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Cincinnati : Forest Investigative Site 008

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Columbus : Forest Investigative Site 031

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Dayton : Forest Investigative Site 041

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

View More »

Mason : Forest Investigative Site 021

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Oklahoma City : Forest Investigative Site 004

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Oklahoma City : Forest Investigative Site 034

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Oklahoma City : Forest Investigative Site 030

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Salem : Forest Investigative Site 005

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Allentown : Forest Investigative Site 014

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Chalfont : Genomind, LLC Updated

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay

Philadelphia : Forest Investigative Site 015

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Lincoln : Lincoln Research - Rhode Island

Anxiety Research Study

View More »

Lincoln : Forest Investigative Site 027

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Memphis : Forest Investigative Site 006

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Memphis : Forest Investigative Site 006

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Houston : Forest Investigative Site 018

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Houston : Forest Investigative Site 008

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Wichita Falls : Forest Investigative Site 017

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Murray : Radiant Research - Salt Lake City

Clinical Research Study for General Anxiety Disorder

Salt Lake City : Optimum Clinical Research, Inc.

Irritable Bowel Syndrome - Diarrhea Predominant

View More »

Salt lake City : Forest Investigative Site 003

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Salt Lake City : Forest Investigative Site 011

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Woodstock : Forest Investigative Site 013

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Charlottesville : Forest Investigative Site 018

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Seattle : Summit Research Network (Seattle) LLC

Anxiety Clinical Research Study

View More »

Bellevue : Forest Investigative Site 040

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Seattle : Forest Investigative Site 039

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Fortaleza : Unidade de Farmacologia Clínica - UNIFAC

Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety

Sao Paulo : SPDM - Associação Paulista para o Desenvolvimento da Medicina - Hospital São Paulo

Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety

Bourgas :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Rousse :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Varna :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Hamilton : MacAnxiety Research Centre

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

Ottawa : The University of Ottawa Institute of Mental Health Research

Cipralex® for Anxiety Disorders in Adolescents

Toronto : Holland Orthopaedic and Arthritic Centre

Perioperative Pregabalin Use, Rehabilitation, Pain Outcomes and Anxiety Following Hip Surgery

Toronto, : START Clinic for Mood and Anxiety Disorders 900-790 Bay St.

An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia

Shanghai : Shanghai Tongji Hospital

Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder

Aalborg : Aalborg University Hospital, Aalborg Psychiatric Hospital, Centre for Schizophrenia

Pregablin for Anxiety-comorbidity in Patients With Schizophrenia

Berlin : DE002

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Mainz : DE001

Pharmacokinetics and Tolerability of Lu AA21004 in Child and Adolescent Patients With Depressive or Anxiety Disorder

Baja N/A :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Budapest :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Kalocsa :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Ahmedabad : Sheth V S General Hospital

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

Bangalore : Spandana Nursing Home

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

Hyderabad : Asha Hospital

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

Lucknow : Manobal Medical Research Centre

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

Mysore : JSS Medical College Hospital

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

View More »

Pune : Poona Hospital & Research Centre

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

Shimoga : Sridhar Neuro Psychiatric Center

A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder

Arad :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Iasi :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Nizny Novgorod :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Saratov :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

St Petersburg :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

St-Peterburg :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

St-Petersburg :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

View More »

Tomsk :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Donetsk :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Glevakha :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Kharkiv :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Kiev :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Odessa :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

View More »

Village Stepanovka Kherson :

A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms